Regulatory role of microRNAs in cancer through Hippo signaling pathway
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Pathology and Forensic Medicine
Reference68 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018
2. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways;Maroufi;Breast Cancer,2020
3. Influence of single nucleotide polymorphism in IL-27 and IL-33 genes on breast cancer;Fathi Maroufi;Br. J. Biomed. Sci.,2019
4. Tissue and serum miRNA profile in locally advanced breast Cancer (LABC) in response to neo-adjuvant chemotherapy (NAC) treatment;Al-Khanbashi;PLoS One,2016
5. Association of rs1946518 C/A polymorphism in promoter region of interleukin 18 gene and breast Cancer risk in iranian women: a case-control study;Maroufi;Iran. J. Allergy Asthma Immunol.,2019
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Circular RNA hsa_circ_00027220-induced regulation of Yes-associated protein promotes platinum resistance in oral squamous cell carcinoma: implications for verteporfin therapy;2024-04-17
2. Breast Cancer Therapeutics and Hippo Signaling Pathway: Novel MicroRNA-Gene-Protein Interaction Networks;OMICS: A Journal of Integrative Biology;2023-06-01
3. MiRNA-93: a novel signature in human disorders and drug resistance;Cell Communication and Signaling;2023-04-19
4. Apelin promotes osteosarcoma metastasis by upregulating PLOD2 expression via the Hippo signaling pathway and hsa_circ_0000004/miR-1303 axis;International Journal of Biological Sciences;2023
5. Chimeric antigen receptor T ( CAR‐T ) cells: Novel cell therapy for hematological malignancies;Cancer Medicine;2022-12-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3